California State Teachers Retirement System (CalSTRS)’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19K Sell
13,704
-234,500
-94% -$322K ﹤0.01% 2463
2025
Q4
$400K Buy
248,204
+504
+0.2% +$1.05K ﹤0.01% 2166
2025
Q3
$676K Buy
247,700
+232,627
+1,543% +$774K ﹤0.01% 1963
2025
Q2
$54.9K Hold
15,073
﹤0.01% 2304
2025
Q1
$28.9K Hold
15,073
﹤0.01% 2427
2024
Q4
$28.6K Hold
15,073
﹤0.01% 2500
2024
Q3
$19.9K Hold
15,073
﹤0.01% 2608
2024
Q2
$15.4K Buy
+15,073
New +$18.6K ﹤0.01% 2700
2022
Q2
Sell
-215,881
Closed -$155K 3130
2022
Q1
$155K Sell
215,881
-19,524
-8% -$41.8K ﹤0.01% 2728
2021
Q4
$532K Buy
235,405
+19,180
+9% +$52.3K ﹤0.01% 2488
2021
Q3
$623K Sell
216,225
-3,980
-2% -$11.4K ﹤0.01% 2392
2021
Q2
$835K Buy
220,205
+4,245
+2% +$14.3K ﹤0.01% 2326
2021
Q1
$731K Sell
215,960
-834
-0.4% -$3K ﹤0.01% 2334
2020
Q4
$607K Hold
216,794
﹤0.01% 2325
2020
Q3
$544K Buy
216,794
+20,526
+10% +$180K ﹤0.01% 2229
2020
Q2
$2.67M Buy
196,268
+17,960
+10% +$186K ﹤0.01% 1287
2020
Q1
$1.35M Sell
178,308
-2,012
-1% -$15.7K ﹤0.01% 1518
2019
Q4
$1.14M Sell
180,320
-3,643
-2% -$17.3K ﹤0.01% 1883
2019
Q3
$721K Buy
183,963
+2,198
+1% +$9.42K ﹤0.01% 2116
2019
Q2
$880K Buy
181,765
+50,394
+38% +$287K ﹤0.01% 2044
2019
Q1
$1.08M Sell
131,371
-3,014
-2% -$20.7K ﹤0.01% 1900
2018
Q4
$743K Buy
134,385
+56,713
+73% +$444K ﹤0.01% 2063
2018
Q3
$686K Buy
77,672
+510
+0.7% +$4.56K ﹤0.01% 2265
2018
Q2
$770K Buy
77,162
+9,125
+13% +$91.4K ﹤0.01% 2222
2018
Q1
$648K Sell
68,037
-2,520
-4% -$35.2K ﹤0.01% 2220
2017
Q4
$1.05M Sell
70,557
-1,029
-1% -$17.1K ﹤0.01% 1978
2017
Q3
$1.41M Buy
71,586
+6,244
+10% +$96K ﹤0.01% 1798
2017
Q2
$939K Sell
65,342
-5,400
-8% -$68.4K ﹤0.01% 2099
2017
Q1
$651K Sell
70,742
-3,200
-4% -$31.2K ﹤0.01% 2332
2016
Q4
$770K Sell
73,942
-2,100
-3% -$18.1K ﹤0.01% 2268
2016
Q3
$688K Buy
76,042
+700
+0.9% +$5.95K ﹤0.01% 2310
2016
Q2
$564K Buy
75,342
+7,446
+11% +$65K ﹤0.01% 2392
2016
Q1
$612K Buy
67,896
+19,909
+41% +$161K ﹤0.01% 2302
2015
Q4
$620K Buy
47,987
+3,660
+8% +$37.3K ﹤0.01% 2285
2015
Q3
$428K Sell
44,327
-200
-0.4% -$1.83K ﹤0.01% 2520
2015
Q2
$458K Buy
44,527
+29,983
+206% +$256K ﹤0.01% 2618
2015
Q1
$162K Hold
14,544
﹤0.01% 2916
2014
Q4
$169K Buy
14,544
+62
+0.4% +$889 ﹤0.01% 2946
2014
Q3
$320K Buy
14,482
+182
+1% +$4.18K ﹤0.01% 2697
2014
Q2
$397K Buy
+14,300
New +$344K ﹤0.01% 2640

Other funds holding AKBA

California State Teachers Retirement System (CalSTRS)'s AKBA Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Akebia Therapeutics (AKBA) stake by 94% in Q1 2026, selling an estimated $322K and leaving 13,704 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #2463.

California State Teachers Retirement System (CalSTRS) first reported a position in AKBA in Q2 2014 and has held it in 40 quarters since. The position peaked at $2.67M in Q2 2020. 171 funds tracked by Wall St. Rank hold AKBA as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 13,704 shares of Akebia Therapeutics worth $19K as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) sold 234,500 Akebia Therapeutics shares in Q1 2026, an estimated $322K.
  • Akebia Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #2463 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Akebia Therapeutics in Q2 2014 and has held it in 40 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Akebia Therapeutics position peaked at $2.67M in Q2 2020.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.